Infectious Disease

Globally, human lifespans have been increasing in large part due to advances in treating and eliminating infectious diseases. Yet, the threat from emerging, reemerging and entrenched infectious diseases remains a challenge for society. Traditional methodology has had success in the past, but with an ever-globalizing world, the need for fast, accurate and comprehensive research is paramount. Partnering with international collaborators is enabling JCVI to be the catalyst for better understanding and potential new treatments against the scourge of infectious disease.

12-Sep-2023
Press Release

J. Craig Venter Institute scientists awarded five-year, $5.7M grant from NIH to develop phage treatment

Phage research accelerates with the rise of antibiotic resistance to address increasingly prevalent and difficult to treat bacterial infections

01-Jun-2023
Collaborator Release

Family resemblance: How T cells could fight many coronaviruses at once

LJI researchers work to head off future pandemics by uncovering key similarities between SARS-CoV-2 and common cold coronaviruses

29-Mar-2023
Collaborator Release

Scientists aim to develop vaccine against all deadly coronaviruses

$8 million NIH grant supports effort to avert next pandemic

24-Mar-2023
Collaborator Release

What are the Drivers of Chronic Infectious Disease?

A $1 million grant from the Steven & Alexandra Cohen Foundation will launch a UC San Diego-led national effort to more deeply study tissue samples from patients with conditions ranging from long COVID-19 and relapsed Lyme disease to chronic fatigue syndrome

The Tissue Analysis Pipeline will be directed by scientists at UC San Diego and the J. Craig Venter Institute

08-Sep-2022
Reuters

Top scientists join forces to study leading theory behind long COVID

Several JCVI scientists will be contributing to the newly launched Long Covid Research Initiative — a collaboration of researchers, clinicians, and patients working to rapidly study and treat long Covid.

13-Jan-2022
Press Release

Omicron and Beta variants evade antibodies elicited by vaccines and previous infections, but boosters help

Pregnancy also contributes to a reduced COVID-19 antibody response

03-Mar-2021
Blog

SARS-CoV-2 Mutation Tracking

25-Feb-2021
Press Release

J. Craig Venter Institute Scientists to Investigate Role of Opioid Abuse in HIV and HIV-Associated Neurocognitive Disorders Pathogenesis through $4.7M NIDA Grant

Study aims to identify candidate molecules to regulate HIV infection in the central nervous system in patients abusing opioids

24-Dec-2020
The San Diego Union Tribune

Scientists rush to determine if mutant strain of coronavirus will deepen pandemic

U.S. researchers have been slow to perform the genetic sequencing that will help clarify the situation

13-Nov-2019
Press Release

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage

09-Jul-2019
Collaborator Release

Combining Antibiotics, Researchers Deliver One-Two Punch against Ubiquitous Bacterium

CWRU/Cleveland VA findings in mouse models could make inroads against superbugs

05-Nov-2018
Blog

Fighting Back Against Flu

20-Feb-2018
Collaborator Release

Past encounters with the flu shape vaccine response

Immune history influences vaccine effectiveness, interacting with other potential problems arising from the manufacturing process